Lueck, Catherina
Tzalavras, Asterios
Wohlfarth, Philipp http://orcid.org/0000-0001-5628-7942
Meedt, Elisabeth
Kiehl, Michael
Turki, Amin T. http://orcid.org/0000-0003-1347-3360
Hoeper, Marius M.
Eder, Matthias
Cserna, Julia
Buchtele, Nina
Wolff, Daniel
Schellongowski, Peter
Beutel, Gernot http://orcid.org/0000-0001-6758-6104
Liebregts, Tobias
Article History
Received: 22 February 2022
Revised: 2 November 2022
Accepted: 9 November 2022
First Online: 10 December 2022
Competing interests
: ATT received honoraria from CSL Behring, MSD and Maat Pharma. CL has received travel subsidies from Jazz Pharmaceuticals and Neovii. DW received honoraria from Novartis, Mallinckrodt, Gilead, Pfizer, Takeda, and Incyte and research support from Novartis. PS received honoraria from Astro-Pharma, Biotest, Jazz Pharmaceuticals, Kite/Gilead, Novartis, Orion, Pfizer and Shire and research support by the European Commission (Horizon 2020 Fast Track Innovation Grant). The other authors declare that they have no competing interests.